Currently, Barbara L. Weber occupies the position of President, Chief Executive Officer & Director at Tango Therapeutics, Inc., President, Chief Executive Officer & Director at Tango Therapeutics Sub, Inc. (a subsidiary of Tango Therapeutics, Inc.) and Venture Partner at Third Rock Ventures LLC. Barbara L. Weber is also on the board of Revolution Medicines, Inc., Fog Pharmaceuticals, Inc. and OPY Acquisition Corp. I and Member of American Society for Clinical Investigation and Member of American Association of Physician Specialists, Inc.

In her past career Dr. Weber occupied the position of Senior VP-Oncology Translational Medicine at Novartis AG, Chief Medical Officer for BioNTech US, Inc., VP-Oncology Discovery & Translational Medicine at GlaxoSmithKline LLC, Professor & Associate at the University of Pennsylvania and Assistant Professor at the University of Michigan.

Dr. Weber received an undergraduate degree and a doctorate from UW Medicine.